Skip to main content

previous disabled Page of 3
and
  1. Article

    Open Access

    Systemic juvenile idiopathic arthritis in French Afro-Caribbean children, a retrospective cohort study

    The epidemiology and clinical presentation of systemic juvenile idiopathic arthritis (sJIA) in the Afro-Caribbean population is not well described.

    A. Felix, F. Delion, B. Suzon, S. Pallara-Sirven, N. Elenga in Pediatric Rheumatology (2022)

  2. Article

    Open Access

    Proceedings of the 23rd Paediatric Rheumatology European Society Congress: part one

    F. De Benedetti, J. Anton, M. Gattorno, H. Lachmann, I. Kone-Paut in Pediatric Rheumatology (2017)

  3. Article

    Open Access

    Proceedings of the 23rd Paediatric Rheumatology European Society Congress: part two

    Olga Lomakina, Ekaterina Alekseeva, Sania Valieva in Pediatric Rheumatology (2017)

  4. Article

    Open Access

    Proceedings of the 23rd Paediatric Rheumatology European Society Congress: part three

    Riccardo Papa, Alessandro Consolaro, Francesca Minoia in Pediatric Rheumatology (2017)

  5. Article

    Open Access

    Probable DRESS syndrome induced by IL-1 inhibitors

    Interleukin (IL)-1 inhibitors have been increasingly used for treating autoinflammatory diseases during the last 10 years, but the spectrum of their possible side effects is not yet fully known. Here, we bring...

    L. Polivka, J. S. Diana, A. Soria, C. Bodemer in Orphanet Journal of Rare Diseases (2017)

  6. Article

    Open Access

    Evidence-based diagnosis and treatment of macrophage activation syndrome in systemic juvenile idiopathic arthritis

    Macrophage activation syndrome (MAS) is a severe and potentially lethal complication of several inflammatory diseases but seems particularly linked to systemic juvenile idiopathic arthritis (sJIA). Standardize...

    V. Boom, J. Anton, P. Lahdenne, P. Quartier, A. Ravelli in Pediatric Rheumatology (2015)

  7. Article

    Open Access

    Genetic and phenotypic characteristics of 114 patients with mevalonate kinase deficiency

    J Jeyaratnam, N ter Haar, H Lachmann, A Simon, P Brogan, M Doglio in Pediatric Rheumatology (2015)

  8. Article

    Open Access

    French Amyloidosis CAPS study: AA Amyloidosis complicating cryopyrin-associated periodic syndrome: a study on 14 cases and review of 53 cases from literature

    S Georgin-Lavialle, K Stankovic Stojanovic, D Buob, P Quartier in Pediatric Rheumatology (2015)

  9. Article

    Open Access

    Cost-effectiveness analysis and prevention effects of ultra-orphan drugs for rare diseases: an in silico model applied to Cryopyrin Associated Periodic Syndromes (CAPS)

    L Trieste, O Della Casa Alberighi, G Turchetti, F Pierotti in Pediatric Rheumatology (2015)

  10. Article

    Open Access

    Long term efficacy and safety of canakinumab in children with systemic juvenile idiopathic arthritis with and without fever

    G Horneff, N Ruperto, H Brunner, P Quartier, T Constantin in Pediatric Rheumatology (2015)

  11. Article

    Open Access

    “Daily life of CAPS patients treated with canakinumab (Ilaris®) : data from the French observational study - ENVOL Study”

    I Koné-Paut, P Quartier, O Fain, G Grateau, P Pillet, P Le Blay in Pediatric Rheumatology (2015)

  12. Article

    Open Access

    The RaDiCEA Project: cost of illness (COI) analysis applied to Cryopyrin Associated Periodic Syndromes (CAPS)

    O Della Casa Alberighi, L Trieste, L Accame, V Lorenzoni in Pediatric Rheumatology (2015)

  13. Article

    Open Access

    Efficacy of canakinumab in biologic-naïve versus previously biologic-exposed SJIA patients: a 12 week pooled post-hoc analysis

    P Quartier, A Grom, N Ruperto, HI Brunner, K Schikler, M Erguven in Pediatric Rheumatology (2014)

  14. Article

    Open Access

    Use of the JADAS criteria to assess efficacy of canakinumab in patients with SJIA – an analysis of 12-week pooled data

    A Ravelli, HI Brunner, N Ruperto, P Quartier, A Consolaro in Pediatric Rheumatology (2014)

  15. Article

    Open Access

    Maintenance of efficacy of canakinumab in SJIA at the individual patient level in a 12-week pooled dataset

    A Ravelli, HI Brunner, N Ruperto, P Quartier, A Consolaro in Pediatric Rheumatology (2014)

  16. Article

    Open Access

    PReS-FINAL-2311: Rituximab in paediatric ANCA-associated vasculitis

    G Mestrallet, A Faye, P Quartier, B Ranchin, P Cochat, A Belot in Pediatric Rheumatology (2013)

  17. Article

    Open Access

    PReS-FINAL-2184: A randomized trial in new onset juvenile dermatomyositis: prednisone versus prednisone plus cyclosporine versus prednisone plus methotrexate

    N Ruperto, A Pistorio, S Knupp Feitosa de Oliveira, R Cuttica in Pediatric Rheumatology (2013)

  18. Article

    Open Access

    PReS13-SPK-1030: Juvenile dermatomyositis

    P Quartier in Pediatric Rheumatology (2013)

  19. Article

    Open Access

    PReS-FINAL-2111: Cytomegalovirus, Epstein Barr virus and Varicella-Zoster virus infections in children with juvenile idiopathic arthritis treated with biologics

    V Remy Piccolo, S Sotou-Bere, A Woerner, R Mouy, B Florkin in Pediatric Rheumatology (2013)

  20. Article

    Open Access

    PReS-FINAL-2191: Imaging of chronic recurrent multifocal osteitis: a french national cohort of 178 cases

    J Wipff, D Nouar, I Lemelle, C Pajot, A Duquesne, M Lorrot in Pediatric Rheumatology (2013)

previous disabled Page of 3